|
Video: What is a Stock Split?
|
|
Rezolute is a clinical-stage biopharmaceutical company developing therapies for metabolic diseases related to chronic glucose imbalance. Co.'s primary clinical asset, RZ358, is a potential treatment for congenital hyperinsulinism, a pediatric genetic disorder characterized by excessive production of insulin by the pancreas. Co.'s second clinical asset, RZ402, is an oral plasma kallikrein inhibitor being developed as a potential therapy for the chronic treatment of diabetic macular edema. According to our Rezolute stock split history records, Rezolute has had 1 split. | |
|
Rezolute (RZLT) has 1 split in our Rezolute stock split history database. The split for RZLT took place on October 13, 2020. This was a 1 for 50
reverse split, meaning for each 50
shares of RZLT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 20 share position following the split.
When a company such as Rezolute conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Rezolute stock split history from start to finish, an original position size of 1000 shares would have turned into 20 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Rezolute shares, starting with a $10,000 purchase of RZLT, presented on a split-history-adjusted basis factoring in the complete Rezolute stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$29.00 |
|
End price/share: |
$2.24 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-92.28% |
|
Average Annual Total Return: |
-22.60% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$772.17 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
10/13/2020 | 1 for 50
|
|
|